Transmission Dynamics of 2019 Novel Coronavirus (2019-nCoV)

Background: Since December 29, 2019, pneumonia infection with 2019-nCoV has rapidly spread out from Wuhan, Hubei Province, China to most others provinces and other counties. However, the transmission dynamics of 2019-nCoV remain unclear. Methods: Data of confirmed 2019-nCoV cases before January 23, 2020 were collected from medical records, epidemiological investigations or official websites. Data of severe acute respiratory syndrome (SARS) cases in Guangdong Province during 2002-2003 were obtained from Guangdong Provincial Center for Disease Control and Prevention (GDCDC). Exponential Growth (EG) and maximum likelihood estimation (ML) were applied to estimate the reproductive number (R) of 2019-nCoV and SARS. Findings: As of January 23, 2020, a total of 830 confirmed 2019-nCoV cases were identified across China, and 9 cases were reported overseas. The average incubation duration of 2019-nCoV infection was 4·8±2·6 days. The average period from onset of symptoms to isolation of 2019-nCoV and SARS cases were 2·9±3·0 and 4·2±3·7 days, respectively. The R values of 2019-nCoV were 2·90 (95%CI: 2·32-3·63) and 2·92 (95%CI: 2·28-3·67) estimated using EG and ML respectively, while the corresponding R values of SARS-CoV were 1·77 (95%CI: 1·37-2·27) and 1·85 (95%CI: 1·32-2·49). We observe a decreasing trend of the period from onset to isolation and R values of both 2019-nCoV and SARS-CoV. Interpretation: The 2019-nCoV may have a higher pandemic risk than SARS broken out in 2003. The implemented public-health efforts have significantly decreased the pandemic risk of 2019-nCoV. However, more rigorous control and prevention strategies and measures to contain its further spread. Funding Statement: National Key Research and Development Program of China (2018YFA0606200, 2018YFA0606202), the Science and Technology Program of Guangdong Province (2018B020207006, 2019B020208005, 2019B111103001), Guangzhou Science and technology Plan Project (201804010383). Declaration of Interests: All authors declare no competing interests. Ethics Approval Statement: Data collection and analysis were determined by the National Health Commission of the People’s Republic of China to be part of a continuing public health outbreak investigation, and were thus considered exempt from institutional review board approval.

[1]  J. Robins,et al.  Transmission Dynamics and Control of Severe Acute Respiratory Syndrome , 2003, Science.

[2]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[3]  S. Lo,et al.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster , 2020, The Lancet.

[4]  J. Parry,et al.  China coronavirus: cases surge as official admits human to human transmission , 2020, BMJ.

[5]  Joshua S Weitz,et al.  A practical generation-interval-based approach to inferring the strength of epidemics from their speed. , 2019, Epidemics.

[6]  Caroline O. Buckee,et al.  Comparing nonpharmaceutical interventions for containing emerging epidemics , 2017, Proceedings of the National Academy of Sciences.

[7]  James O Lloyd-Smith,et al.  Dynamically Modeling SARS and Other Newly Emerging Respiratory Illnesses: Past, Present, and Future , 2005, Epidemiology.

[8]  J. Wallinga,et al.  Different Epidemic Curves for Severe Acute Respiratory Syndrome Reveal Similar Impacts of Control Measures , 2004, American journal of epidemiology.

[9]  C. Fraser,et al.  Factors that make an infectious disease outbreak controllable. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[10]  M. Lipsitch,et al.  How generation intervals shape the relationship between growth rates and reproductive numbers , 2007, Proceedings of the Royal Society B: Biological Sciences.

[11]  L Forsberg White,et al.  A likelihood‐based method for real‐time estimation of the serial interval and reproductive number of an epidemic , 2008, Statistics in medicine.